Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature

Incidence of Differentiation Syndrome Associated with Treatment Regimens in Acute Myeloid Leukemia: A Systematic Review of the Literature

Differentiation syndrome (DS) is a potentially fatal adverse drug reaction caused by the so-called differentiating agents such as all-trans retinoic acid (ATRA) and arsenic trioxide (ATO), used for remission induction in the treatment of the M3 subtype of acute myeloid leukemia (AML), acute promyelo...

Full description

Bibliographic Details
Main Authors: Lucia Gasparovic, Stefan Weiler, Lukas Higi, Andrea M. Burden
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
differentiation syndrome
retinoic acid syndrome
differentiating agents
acute myeloid leukemia
non-M3 acute myeloid leukemia
acute promyelocytic leukemia
Online Access:https://www.mdpi.com/2077-0383/9/10/3342

Similar Items

Similar Items